Government of Nepal
Ministry of Health and Population
Department of Health Services
Epidemiology and Disease Control Division
Protocol for using Bamlanivimab & Etesevimab Anti-SARS-Cov-2 Monoclonal Antibodies
Jan 1
2024_12_03_Dengue Situation Update
2024_10_28_Dengue Situation Update
DOWNLOAD
